1. Vincent A, Lily O, Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders[J]. Journal of neuroimmunology, 1999, 100(1-2): 169-180.
2. Wirtz PW, Smallegange TM, Wintzen AR, et al. Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg 2002;104:359-63.
3. Merino-Ramírez M Á, Bolton C F. Review of the diagnostic challenges of Lambert–Eaton syndrome revealed through three case reports[J]. Canadian Journal of Neurological Sciences, 2016, 43(5): 635-647.